Skip to main content
Premium Trial:

Request an Annual Quote

X Prize Foundation to Announce $10M Genome Sequencing Award Tomorrow

NEW YORK (GenomeWeb News) – The X Prize Foundation tomorrow plans to announce the $10M Genome X Prize, the organization said today.
As GenomeWeb News reported in February, the genomics community had been anticipating the foundation’s second prize to address a technology for rapid, cheap whole-genome sequencing.
At the time, X Prize spokesperson Ian Murphy said the genome award could run between $5 million and $20 million. Organizers have said in the past that one goal could be to award the first team to decode the DNA of 100 or more people in a matter of weeks.
Murphy has said the foundation doesn't expect anyone to claim the prize for at least five to 10 years.
The annoucnement will be made at a press conference at the National Press Club at 10 AM Eastern time. Participants will include Craig Venter; Francis Collins; Peter Diamandis, founder and chairman of the X Prize Foundation; Stewart Blusson, president of Archon Minerals; and Sharon Terry, president and CEO of the Genetic Alliance.
The non-profit X Prize Foundation, based in Santa Monica, Calif., uses huge cash awards to encourage scientific innovation. It awarded its first prize of $10 million in 2004 to Mojave Aerospace Ventures for flying a specially designed aircraft to the sub-orbital altitude of 100 kilometers on two consecutive flights, within two weeks.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.